HPV相关疾病市场：按适应症（AIN、肛门癌、宫颈癌）、治疗（预防、治疗）、分布 - 俄罗斯-乌克兰衝突和高通胀 - 2023-2030年全球预测

HPV相关疾病的全球市场预计将显着增长，预计到2023年将达到93.0382亿美元，年复合成长率为6.07%，预计到2030年将达到惊人的1411219万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球HPV相关疾病市场至关重要。通过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.HPV相关疾病的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球HPV相关疾病市场的抑制要素和影响是什么？

3.预测期内全球HPV相关疾病市场需要投资哪些产品/细分市场/应用/领域？

4.HPV相关疾病全球市场的竞争策略是什么？

5.全球HPV相关疾病市场的技术趋势和法律规范是什么？

6.全球HPV相关疾病市场主要厂商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入HPV相关疾病的全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • HPV 相关疾病的患病率上升
    • 标靶治疗的生长发育
    • 政府积极支持并努力解决 HPV 疾病
  • 抑制因素
    • 与 HPV 相关的副作用
  • 机会
    • 增加癌症研究的资金和投资
    • HPV联合检测技术进展
  • 课题
    • 患者对某些治疗方案缺乏认识
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户定制

第6章HPV 相关疾病市场：按适应症分类

• 介绍
• AIN
• 肛门癌
• 宫颈癌
• CIN
• 尖锐湿疣

第7章HPV 相关疾病市场：按治疗分类

• 介绍
• 预防
• 治疗

第8章HPV 相关疾病市场：按分布

• 介绍
• 医院药房
• 网上药房
• 零售药房

第9章美洲HPV相关疾病市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太地区HPV相关疾病市场

• 介绍
• 澳大利亚
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲、中东和非洲HPV相关疾病市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 意大利
• 荷兰
• 尼日利亚
• 挪威
• 波兰
• 卡塔尔
• 俄罗斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯联合酋长国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市场份额分析：主要企业
• 竞争情景分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可和定价

The Global HPV Associated Disorders Market is forecasted to grow significantly, with a projected USD 9,303.82 million in 2023 at a CAGR of 6.07% and expected to reach a staggering USD 14,112.19 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global HPV Associated Disorders Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global HPV Associated Disorders Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across AIN, Anal Cancer, Cervical Cancer, CIN, and Genital Warts. The AIN is projected to witness significant market share during forecast period.

Based on Therapy, market is studied across Prevention and Treatment. The Treatment is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.00% in 2022, followed by Asia-Pacific.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global HPV Associated Disorders Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global HPV Associated Disorders Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global HPV Associated Disorders Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global HPV Associated Disorders Market?

4. What is the competitive strategic window for opportunities in the Global HPV Associated Disorders Market?

5. What are the technology trends and regulatory frameworks in the Global HPV Associated Disorders Market?

6. What is the market share of the leading vendors in the Global HPV Associated Disorders Market?

7. What modes and strategic moves are considered suitable for entering the Global HPV Associated Disorders Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. HPV Associated Disorders Market, by Indication, 2022 vs 2030
• 4.3. HPV Associated Disorders Market, by Therapy, 2022 vs 2030
• 4.4. HPV Associated Disorders Market, by Distribution, 2022 vs 2030
• 4.5. HPV Associated Disorders Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of HPV related diseases
    • 5.1.1.2. Growth and development in targeted therapies
    • 5.1.1.3. Proactive government support and initiatives for HPV disorders awareness
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse effects associated with HPV
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased funding and investment for cancer research
    • 5.1.3.2. Growing technological advancement in HPV co-testing
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of patient awareness regarding several treatments options
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. HPV Associated Disorders Market, by Indication

• 6.1. Introduction
• 6.2. AIN
• 6.3. Anal Cancer
• 6.4. Cervical Cancer
• 6.5. CIN
• 6.6. Genital Warts

7. HPV Associated Disorders Market, by Therapy

• 7.1. Introduction
• 7.2. Prevention
• 7.3. Treatment

8. HPV Associated Disorders Market, by Distribution

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas HPV Associated Disorders Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific HPV Associated Disorders Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa HPV Associated Disorders Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

1. Alembic Pharmaceuticals

2. AstraZeneca plc

3. Bausch Health Companies Inc

4. Biocon Ltd.

5. Bristol-Myers Squibb Co.

6. Eli Lilly and Company.

7. F. Hoffmann-La Roche Ltd

8. GEA Group Aktiengesellschaft

9. GlaxoSmithKline plc

10. Inovio Pharmaceuticals, Inc.

11. J.M. Huber Corporation

12. Johnson & Johnson Services, Inc.

13. KinoPharma, Inc.

14. Merck & Co., Inc.

15. Novartis AG

16. Pfizer, Inc.

LIST OF FIGURES

• FIGURE 1. HPV ASSOCIATED DISORDERS MARKET RESEARCH PROCESS
• FIGURE 2. HPV ASSOCIATED DISORDERS MARKET SIZE, 2022 VS 2030
• FIGURE 3. HPV ASSOCIATED DISORDERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2022 VS 2030 (%)
• FIGURE 6. HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 7. HPV ASSOCIATED DISORDERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. HPV ASSOCIATED DISORDERS MARKET DYNAMICS
• FIGURE 9. HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. HPV ASSOCIATED DISORDERS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. HPV ASSOCIATED DISORDERS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HPV ASSOCIATED DISORDERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HPV ASSOCIATED DISORDERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. HPV ASSOCIATED DISORDERS MARKET SIZE, BY AIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. HPV ASSOCIATED DISORDERS MARKET SIZE, BY ANAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HPV ASSOCIATED DISORDERS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HPV ASSOCIATED DISORDERS MARKET SIZE, BY CIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. HPV ASSOCIATED DISORDERS MARKET SIZE, BY GENITAL WARTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 11. HPV ASSOCIATED DISORDERS MARKET SIZE, BY PREVENTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. HPV ASSOCIATED DISORDERS MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 14. HPV ASSOCIATED DISORDERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HPV ASSOCIATED DISORDERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. HPV ASSOCIATED DISORDERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 29. CANADA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 44. CHINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 46. CHINA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. INDIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 49. INDIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. ITALY HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 101. ITALY HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. POLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 113. POLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. QATAR HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 116. QATAR HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM HPV ASSOCIATED DISORDERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM HPV ASSOCIATED DISORDERS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM HPV ASSOCIATED DISORDERS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. HPV ASSOCIATED DISORDERS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 145. HPV ASSOCIATED DISORDERS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 146. HPV ASSOCIATED DISORDERS MARKET LICENSE & PRICING